92 related articles for article (PubMed ID: 3469468)
1. Synergism or antagonism between estradiol and progesterone on the cell kinetic parameters of the MXT mouse mammary tumor.
Kiss R; Danguy AJ; Heuson JC; Paridaens RJ
J Natl Cancer Inst; 1987 Mar; 78(3):573-9. PubMed ID: 3469468
[TBL] [Abstract][Full Text] [Related]
2. Effect of prolactin and estradiol on cell proliferation in the uterus and the MXT mouse mammary neoplasm.
Kiss R; de Launoit Y; L'Hermite-Balériaux M; L'Hermite M; Paridaens RJ; Danguy AJ; Pasteels JL
J Natl Cancer Inst; 1987 May; 78(5):993-8. PubMed ID: 3472006
[TBL] [Abstract][Full Text] [Related]
3. Hormonal regulation of uterine epithelial cell proliferation. I. Effects of estradiol or progesterone administered separately.
Kiss R; Lenglet G; Pasteels JL; Danguy A
In Vivo; 1987; 1(5):281-9. PubMed ID: 2979795
[TBL] [Abstract][Full Text] [Related]
4. Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm.
Kiss R; Paridaens RJ; Heuson JC; Danguy AJ
J Natl Cancer Inst; 1986 Jul; 77(1):173-8. PubMed ID: 3459912
[TBL] [Abstract][Full Text] [Related]
5. Effect of castration and 17 beta-estradiol pulse on cell proliferation in the uterus and the MXT mouse mammary tumor.
Paridaens RJ; Danguy AJ; Leclercq G; Kiss R; Heuson JC
J Natl Cancer Inst; 1985 Jun; 74(6):1239-46. PubMed ID: 3858596
[TBL] [Abstract][Full Text] [Related]
6. Effect of estradiol -17- beta (E2) on cell proliferation in the uterus and the MXT mammary tumor borne by intact, ovariectomized and/or hypophysectomized mice.
de Launoit Y; Kiss R; Paridaens R; Danguy A; Pasteels JL
In Vivo; 1987; 1(3):173-9. PubMed ID: 2979783
[TBL] [Abstract][Full Text] [Related]
7. Hormonal regulation of uterine epithelial cell proliferation. II. Effects of estradiol and progesterone administered in combination.
Kiss R; Lenglet G; Pasteels JL; Danguy A
In Vivo; 1987; 1(5):291-6. PubMed ID: 2979796
[TBL] [Abstract][Full Text] [Related]
8. Effect of estradiol on proliferation and on cell loss in the MXT mouse mammary tumor.
Kiss R; Danguy A; Heuson JC; Paridaens R
Anticancer Res; 1986; 6(6):1321-8. PubMed ID: 3813488
[TBL] [Abstract][Full Text] [Related]
9. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors.
Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654
[TBL] [Abstract][Full Text] [Related]
10. MXT mammary tumor treated by low dose chemotherapy. A 31P-NMR and 1H-MRI study.
Scheiber C; Kiss R; De Launoit Y; Frühling J
Anticancer Res; 1988; 8(3):403-7. PubMed ID: 2839100
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of the hormone dependent MXT-mouse mammary carcinoma to estradiol during tumoral growth. An autoradiographic study.
Kiss R; Paridaens R; Leclercq G; Danguy A
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):849-56. PubMed ID: 3770041
[TBL] [Abstract][Full Text] [Related]
12. Proliferative responses of mouse mammary glands to 17 beta-estradiol and progesterone and modification by mouse mammary tumor virus.
Lee AE
J Natl Cancer Inst; 1983 Dec; 71(6):1265-9. PubMed ID: 6317935
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.
Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ
Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489
[TBL] [Abstract][Full Text] [Related]
14. Effect of ovariectomy, hypophysectomy and/or GnRH analog (HRF) administration on the cell proliferation of the MXT mouse hormone-dependent mammary tumor.
de Launoit Y; Kiss R; Danguy A; Paridaens R
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1443-50. PubMed ID: 3315693
[TBL] [Abstract][Full Text] [Related]
15. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
16. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
Janik P; Briand P; Hartmann NR
Cancer Res; 1975 Dec; 35(12):3698-704. PubMed ID: 1192428
[TBL] [Abstract][Full Text] [Related]
17. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
18. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
19. Effects of combination estrogen:cyclophosphamide treatment on the growth of the MXT transplantable mammary tumor in the mouse.
Markaverich BM; Medina D; Clark JH
Cancer Res; 1983 Jul; 43(7):3208-11. PubMed ID: 6850631
[TBL] [Abstract][Full Text] [Related]
20. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents.
Matsuzawa A; Ikeda Y
Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
